Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells
Do Hyung Kim,1,2,* Young-Il Jeong,1,* Chung-Wook Chung,1 Cy Hyun Kim,1,2 Tae Won Kwak,1 Hye Myeong Lee,1 Dae Hwan Kang1,21National Research and Development Center for Hepatobiliary Cancer, Pusan National University Yangsan Hospital, 2School of Medicine, Pusan National University, Yangsan, Gyeongsang...
Enregistré dans:
Auteurs principaux: | Kim DH, Jeong YI, Chung CW, Kim CH, Kwak TW, Lee HM, Kang DH |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a24dbd7dffcd426d9c4762c3d3a588ea |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Vorinostat-eluting poly(DL-lactide-co-glycolide) nanofiber-coated stent for inhibition of cholangiocarcinoma cells
par: Kwak TW, et autres
Publié: (2017) -
Synergistic effects of 5-aminolevulinic acid based photodynamic therapy and celecoxib via oxidative stress in human cholangiocarcinoma cells
par: Kim CH, et autres
Publié: (2013) -
Effect of 5-aminolevulinic acid-based photodynamic therapy via reactive oxygen species in human cholangiocarcinoma cells
par: Kang DH, et autres
Publié: (2011) -
Dextran-b-poly(L-histidine) copolymer nanoparticles for pH-responsive drug delivery to tumor cells
par: Hwang JH, et autres
Publié: (2013) -
5-aminolevulinic acid-incorporated poly(vinyl alcohol) nanofiber-coated metal stent for application in photodynamic therapy
par: Kang DH, et autres
Publié: (2012)